High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts

Abstract

HGGs in AYAs could benefit from a specific classification, driven by molecular subtyping rather than age group. Collaborative efforts are needed from pediatric and adult neuro-oncology teams to improve the management of HGGs in AYAs.